title: Authors' reply: immunodeficiency at the start of combination antiretroviral therapy: steady improvement or step changes?
authors.affiliation: *Institute for Social & Preventive Medicine (ISPM), University of Bern, Switzerland †Center for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa ‡Department of Epidemiology, Johns Hopkins Bloomberg, School of Public Health, Baltimore, MD.
authors.forename: Manuel
authors.initials: M
authors.lastname: Koller
authors.forename: Keri N
authors.initials: KN
authors.lastname: Althoff
authors.forename: Mary-Ann
authors.initials: MA
authors.lastname: Davies
authors.forename: Matthias
authors.initials: M
authors.lastname: Egger
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count / Q000706:statistics & numerical data*; D019049:Developed Countries / Q000706:statistics & numerical data*; D003906:Developing Countries / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D019380:Anti-HIV Agents